Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Y Zhong, J Zhang, R Cheng, C Deng, F Meng… - Journal of controlled …, 2015 - Elsevier
The existence of drug resistance poses a major obstacle for the treatment of various
malignant human cancers. Here, we report on reduction-sensitive reversibly crosslinked …
被引用次数：285 相关文章

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts …

Y Zhong, J Zhang, R Cheng, C Deng… - Journal of Controlled …, 2015 - europepmc.org
The existence of drug resistance poses a major obstacle for the treatment of various
malignant human cancers. Here, we report on reduction-sensitive reversibly crosslinked …

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Y Zhong, J Zhang, R Cheng, C Deng, F Meng… - Journal of Controlled …, 2015 - infona.pl
The existence of drug resistance poses a major obstacle for the treatment of various
malignant human cancers. Here, we report on reduction-sensitive reversibly crosslinked …

[引用][C] Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor …

Y ZHONG, J ZHANG, R CHENG, C DENG… - Journal of Controlled …, 2015 - jglobal.jst.go.jp
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent
delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts | Article …
[PDF] suda.edu.cn

[PDF][PDF] Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor …

Y Zhong, J Zhang, R Cheng, C Deng… - Journal of Controlled …, 2015 - bmp.suda.edu.cn
Yinan Zhong a, Jian Zhang a, Ru Cheng a,⁎, Chao Deng a, Fenghua Meng a, Fang Xie b,⁎,
Zhiyuan Zhong a,⁎ a Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of …

[引用][C] Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor …

Y Zhong, J Zhang, R Cheng, C Deng, F Meng… - Journal of Controlled …, 2015 - cir.nii.ac.jp
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery
of doxorubicin to drug resistant CD44+ human breast tumor xenografts | CiNii Research CiNii …

Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts

Y Zhong, J Zhang, R Cheng, C Deng… - … : official journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
The existence of drug resistance poses a major obstacle for the treatment of various
malignant human cancers. Here, we report on reduction-sensitive reversibly crosslinked …
[PDF] suda.edu.cn

[PDF][PDF] Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor …

Y Zhong, J Zhang, R Cheng, C Deng… - Journal of Controlled …, 2015 - bmp.suda.edu.cn
Yinan Zhong a, Jian Zhang a, Ru Cheng a,⁎, Chao Deng a, Fenghua Meng a, Fang Xie b,⁎,
Zhiyuan Zhong a,⁎ a Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of …

[引用][C] Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor …

Y Zhong, J Zhang, R Cheng, C Deng, F Meng, F Xie… - 2015